Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A 4-week, multicentre, randomized, double-blind, double-dummy, parallel group ambulatory blood pressure monitoring study to demonstrate that treatment with lumiracoxib 100 mg o.d. results in a 24-hour blood pressure profile superior to ibuprofen 600 mg t.i.d. in OA patients with controlled hypertension https://kusajili.com:443/Trial/fvNqpCle9UWc5qzDvjYgSQ%24a-4-week-multicentre-randomized-double-blind-double-dummy-parallel-group-ambulatory-blood-pressure-monitoring-study-to-demonstr
I have read and accept the terms of use of the site and the Privacy Policy
Send your message